CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K/A Event Acquisition or sale completed
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 8-K Event Executive or director change · Shareholder vote results · Other events
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Other events
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Material agreement · New debt or obligation
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation · Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 10-K Report Annual Report
Page 3 of 4 · 63 filings